Pimavanserin 34 mg capsule
PIMASERIN 34 is a breakthrough antipsychotic medication containing Pimavanserin 34 mg, specifically developed for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis (PDP). It is the first and only FDA-approved therapy designed exclusively for PDP and offers a novel approach to managing symptoms without worsening the motor impairments commonly seen in Parkinson’s patients.
Unlike traditional antipsychotics, PIMASERIN 34 does not interfere with dopamine receptors, which are essential for motor function. This makes it an ideal option for patients suffering from Parkinson’s disease, who are often particularly sensitive to dopamine-blocking medications.
PIMASERIN 34 provides targeted relief from psychotic symptoms, improves patient quality of life, and reduces caregiver burden, all while preserving motor control and minimizing sedative effects.
Key Features and Ingredients
Pimavanserin 34 mg
Pimavanserin is a selective serotonin inverse agonist and antagonist that primarily targets 5-HT2A receptors. These receptors are strongly implicated in the development of hallucinations and delusions in Parkinson’s disease. By modulating these receptors without affecting dopamine signaling, PIMASERIN 34 delivers symptom relief with a lower risk of motor-related side effects.
Non-Dopaminergic Mechanism
Unlike conventional antipsychotics, PIMASERIN 34 does not block dopamine D2 receptors. This is a key differentiator, as dopamine antagonism can worsen tremors, rigidity, and bradykinesia in Parkinson’s patients. The selective action of pimavanserin allows for effective psychosis management while preserving motor function.
Well-Tolerated Formulation
PIMASERIN 34 is administered once daily and does not require titration. It is generally well-tolerated, with a low incidence of extrapyramidal symptoms, sedation, or orthostatic hypotension—common side effects seen with traditional antipsychotic therapy.
Usage Instructions
Dosage: The standard recommended dose is 34 mg once daily, administered orally.
Administration: Can be taken with or without food. Swallow the tablet whole with water.
Duration: Continue therapy as prescribed. Do not discontinue use abruptly without consulting a healthcare provider.
Monitoring: Regular follow-up is recommended to assess efficacy, tolerability, and any potential side effects.
Important: Always follow your physician’s dosage and administration instructions. If a dose is missed, take it as soon as you remember unless it is near the time of the next dose.
Benefits of PIMASERIN 34
Effective Management of Parkinson’s Disease Psychosis
PIMASERIN 34 significantly reduces hallucinations and delusions—the hallmark symptoms of Parkinson’s disease psychosis—without compromising the motor functions critical to quality of life in Parkinson’s patients.
Preserves Motor Function
Due to its non-dopaminergic mechanism, PIMASERIN 34 does not worsen symptoms like tremors, slowness, or muscle rigidity, which are often aggravated by other antipsychotic medications.
Improves Quality of Life
By alleviating disturbing psychotic symptoms, PIMASERIN 34 helps restore emotional well-being, improves sleep quality, and enhances social functioning. It also helps reduce stress for caregivers and healthcare providers managing the patient's condition.
Reduced Risk of Sedation and Cognitive Impairment
Unlike traditional antipsychotics, PIMASERIN 34 has a minimal sedative effect and does not worsen cognitive function, making it particularly suitable for elderly or cognitively impaired patients.
Convenient Once-Daily Dosing
The simple once-daily regimen ensures better compliance and consistent therapeutic levels, making it easier for patients and caregivers to adhere to treatment plans.
Conclusion
PIMASERIN 34 represents a significant advancement in the treatment of Parkinson’s disease psychosis, offering a safer and more targeted solution than traditional antipsychotic therapies. With its unique serotonin-based mechanism, it effectively addresses hallucinations and delusions without interfering with dopamine, ensuring that motor symptoms are preserved and quality of life is enhanced. Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options. The company offers a wide range of healthcare products, catering to various medical needs, from rare disease treatments to essential healthcare products. Sterispharma's product range includes solutions for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. Medicines can be conveniently ordered via Our websites—Sterisonline, Sterisindia, and Sterispharma.
For further information
Email: info@sterispharma.com / contact@sterispharma.com
Call/WhatsApp: 8209542042 , 8824175417
